Course Exam
301907 VO Development of novel cancer immunotherapies (2019W)
from target identification through target validation to clinical trials
Labels
WHEN?
Wednesday
26.02.2020
9.00 Uhr SR 4/BZB, Dr.Bohrgasse 9/6.Stock, 1030 Wien
Registration/Deregistration
Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
- Registration is open from Tu 01.10.2019 09:00 to Tu 25.02.2020 09:00
- Deregistration possible until Tu 25.02.2020 09:00
Examiners
Information
Assessment and permitted materials
written exam
Minimum requirements and assessment criteria
100-87%: Sehr Gut ( I ); 87,99-75%: Gut (2); 74,99-62%: Befriedigend (3); 6 I ,99-50%: Genügend (4); < 50%: Nicht Genügend (5)
Last modified: We 19.08.2020 07:49